{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:12:05Z","timestamp":1774465925872,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ejmg.2019.103751","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T02:03:14Z","timestamp":1566871394000},"page":"103751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome"],"prefix":"10.1016","volume":"63","author":[{"given":"Willem M.A.","family":"Verhoeven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos I.M.","family":"Egger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"de Leeuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2019.103751_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajmg.a.35700","article-title":"Cerebellar and fossa posterior malformations in patients with autism-associated chromosome 22q13 terminal deletion","volume":"161A","author":"Aldinger","year":"2013","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.1978.tb02357.x","article-title":"The CPRS. Development and applications of a psychiatric rating scale","volume":"271","author":"\u00c5sberg","year":"1978","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.ejmg.2019.103751_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmg.2016.08.003","article-title":"Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor","volume":"59","author":"Breckpot","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia. I. Rating scale and standardized examination","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ejmg.2019.103751_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2014.00061","article-title":"New experimental treatments for core social domain in autism spectrum disorders","volume":"2","author":"Canitano","year":"2014","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ejmg.2019.103751_bib6","first-page":"10r01097","article-title":"The clinical management of bipolar disorder: a review of evidence-based guidelines","volume":"13","author":"Connolly","year":"2011","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.ejmg.2019.103751_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s13311-015-0352-z","article-title":"Phelan-McDermid syndrome and SHANK3: implications for treatment","volume":"12","author":"Costales","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmg.2019.103751_bib9","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2147\/NDT.S106479","article-title":"A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts","volume":"12","author":"Dell'Osso","year":"2016","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejmg.2019.103751_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000339119","article-title":"Neuropsychopathology in 7 patients with the 22q13.3 deletion syndrome: presence of bipolar disorder and progressive loss of skills","volume":"3","author":"Denayer","year":"2012","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.ejmg.2019.103751_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajmg.c.30155","article-title":"22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay","volume":"145C","author":"Cusmano-Ozog","year":"2007","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13229-018-0205-9","article-title":"Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations","volume":"9","author":"De Rubeis","year":"2018","journal-title":"Mol. Autism."},{"key":"10.1016\/j.ejmg.2019.103751_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/gbb.12285","article-title":"Neuropsychologische fenotype and psychopathology in seven adult patients with Phelan-McDermid syndrome: implications for treatment strategy","volume":"15","author":"Egger","year":"2016","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.ejmg.2019.103751_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220778","article-title":"Phelan-McDermid syndrome due to SHANK3 mutation in an intellectually disabled adult male: successful treatment with lithium","author":"Egger","year":"2017","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ejmg.2019.103751_bib14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.seizure.2014.06.008","article-title":"Seizures and EEG pattern in the 22q13.3 deletion syndrome: clinical report of six Italian cases","volume":"23","author":"Figura","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.ejmg.2019.103751_bib15","series-title":"Catatonia: a Clinician's Guide to Diagnosis and Treatment","author":"Fink","year":"2003"},{"key":"10.1016\/j.ejmg.2019.103751_bib16","doi-asserted-by":"crossref","first-page":"19544","DOI":"10.1038\/srep19544","article-title":"Mitochondrial dysfunction may explain symptom variation in Phelan-McDermid syndrome","volume":"6","author":"Frye","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmg.2019.103751_bib17","first-page":"520","article-title":"Onderzoek met de CPRS in Nederlandse vertaling. Betrouwbaarheid, factorstructuur en intensiteitsbeoordeling","volume":"36","author":"Goekoop","year":"1994","journal-title":"Tijschr. Psychiatrie."},{"key":"10.1016\/j.ejmg.2019.103751_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/dneu.22128","article-title":"The emerging role of SHANK genes in neuropsychiatric disorders","volume":"74","author":"Guilmatre","year":"2014","journal-title":"Develop. Neurobiol."},{"key":"10.1016\/j.ejmg.2019.103751_bib19","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1177\/0883073815600872","article-title":"Phelan McDermid Syndrome: from genetic discoveries to animal models and treatments","volume":"30","author":"Harony-Nicolas","year":"2015","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ejmg.2019.103751_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18904","article-title":"Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat","volume":"6","author":"Harony-Nicolas","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.ejmg.2019.103751_bib21","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/epi.13506","article-title":"The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss of function mutations","volume":"57","author":"Holder","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejmg.2019.103751_bib22","article-title":"Psychiatric assessment in Phelan-McDermid syndrome (22q13 deletion syndrome)","author":"Kildahl","year":"2018","journal-title":"J. Intellect. Dev. Disabil."},{"key":"10.1016\/j.ejmg.2019.103751_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1866-1955-6-39","article-title":"Phelan-McDermid syndrome: review of the literature and practice parameters for medical assessment and monitoring","volume":"6","author":"Kolevzon","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.ejmg.2019.103751_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2040-2392-5-54","article-title":"A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome","volume":"5","author":"Kolevson","year":"2014","journal-title":"Mol. Autism."},{"key":"10.1016\/j.ejmg.2019.103751_bib25","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/jmg.40.9.690","article-title":"Telomeric 22q13.3 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations","volume":"40","author":"Luciani","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40263-014-0143-9","article-title":"Catatonia in patients with autism: prevalence and management","volume":"28","author":"Mazzone","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmg.2019.103751_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41431-017-0042-x","article-title":"Identification of 22q13 genes most likely to contribute to Phelan-McDermid syndrome","volume":"26","author":"Mitz","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13023-015-0323-9","article-title":"Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations","volume":"10","author":"Oberman","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejmg.2019.103751_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1172-3-14","article-title":"Deletion 22q13.3 syndrome","volume":"3","author":"Phelan","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejmg.2019.103751_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000334260","article-title":"The 22q13.3 deletion syndrome (Phelan-McDermid syndrome)","volume":"2","author":"Phelan","year":"2011","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.ejmg.2019.103751_bib31","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1542\/peds.2007-2584","article-title":"Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood","volume":"122","author":"Philippe","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejmg.2019.103751_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpsychires.2017.03.010","article-title":"Characterizing regression in Phelan McDermid syndrome (22q13 deletion syndrome)","volume":"91","author":"Reierson","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejmg.2019.103751_bib33","series-title":"Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities\/mental Retardation","author":"Royal College of Psychiatrists DC-LD","year":"2001"},{"key":"10.1016\/j.ejmg.2019.103751_bib34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00439-014-1423-7","article-title":"Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome","volume":"133","author":"Sarasua","year":"2014","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12888-015-0490-1","article-title":"Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports","volume":"15","author":"Serret","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ejmg.2019.103751_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nature12618","article-title":"Shank 3 and IGF1 restore synaptic deficits in neurons from 22q13.3 deletion syndrome patients","volume":"503","author":"Shcheglovitov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmg.2019.103751_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.2008.062141","article-title":"Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial","volume":"46","author":"Schmidt","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2018.09.008","article-title":"Volumetric analysis of the basal ganglia an cerebellar structures in patients with Phelan-McDermid syndrome","volume":"90","author":"Srivastava","year":"2019","journal-title":"Pediatr. Neurol. doi.org"},{"key":"10.1016\/j.ejmg.2019.103751_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41525-017-0035-2","article-title":"A framework to identify contributing genes in patients with Phelan-McDermid syndrome","volume":"2","author":"Tabet","year":"2017","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.ejmg.2019.103751_bib40","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2174\/1570159X13666151029105547","article-title":"Novel therapeutic approach for autism spectrum disorder: focus on SHANK3","volume":"13","author":"Uchino","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmg.2019.103751_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/NDT.S30506","article-title":"Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?","volume":"8","author":"Verhoeven","year":"2012","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejmg.2019.103751_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ajmg.a.35597","article-title":"Phelan-McDermid syndrome: clinical report of a 70-year-old women","volume":"161A","author":"Verhoeven","year":"2013","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejmg.2012.07.009","article-title":"Bipolar affective disorder and early dementia onset in a male patient with SHANK3 deletion","volume":"55","author":"Vucurovic","year":"2012","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmg.40.8.575","article-title":"Molecular characterisation of the 22q13 deletion syndrome supports the role ,f haploinsufficiency of SHANK3\/PROSAP2 in the major neurological symptoms","volume":"40","author":"Wilson","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2019.103751_bib45","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/ejhg.2016.109","article-title":"Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double blind, placebo-controlled trial","volume":"24","author":"Zwanenburg","year":"2016","journal-title":"Eur. J. Hum. Genet."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721218309066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721218309066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:48:58Z","timestamp":1761709738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721218309066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1769721218309066"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2019.103751","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2019.103751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103751"}}